Clorox (CLX) Tops Q1 EPS by 14c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Clorox (CLX) 1Q16 EPS Beat Driven by Top-Line Growth; UBS Raises Price Target to $105
November 3, 2015 8:43 AM ESTUBS reiterated a Sell rating on Clorox (NYSE: CLX), and raised the price target to $105.00 (from $103.00), following the company's 1Q16 earnings results. CLX posted a sizeable Q1 beat, delivering $1.32 in EPS (20% YOY growth) vs. consensus of $1.18. This outperformance was driven by greater FX-neutral top-line... More
